CLINICAL_TRIALS trial_result · 2024-12-19

Clinical Trial Update: A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease [Phase 1]

Phase 1 trial evaluating vonoprazan in children with symptomatic gastroesophageal reflux disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Phathom Pharmaceuticals, Inc. | Conditions: Gastroesophageal Reflux Disease | Phase 1 | Status: COMPLETED | Results posted: 2024-12-19